Mythbusters from WHO

The World Health Organization (WHO) has produced a set of ‘Mythbusters’ relating to COVID-19, each with a graphic that can be downloaded and shared. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/advice-for-public/myth-busters  

COVID-19: GINA Answers to Frequently Asked Questions on asthma management

March 25, 2020 Follow GINA at @ginasthma People with asthma should continue all of their inhaled medication, including inhaled corticosteroids, as prescribed by their doctor. Inacute asthma attacks patients should take a short course of oral corticosteroids if instructed in their asthma action plan or by their healthcare provider, to prevent serious consequences. In rare cases, patients with severe asthma …

Recommendations for inhaled asthma controller medications

(scroll down for translated versions) People with asthma should continue to use their inhaled asthma controller medications during the COVID-19 epidemic GINA FAQs to frequently asked questions on asthma management Some sources have suggested that “corticosteroids” should be avoided during the COVID-19 epidemic. This advice is about the use of oral corticosteroids unless there is …

Are the 2019 Global Initiative for Asthma (GINA) strategy recommendations applicable to the Canadian context?

Read the “Canadian Journal of Respiratory, Critical Care, and Sleep Medicine’s article,  “Are the 2019 Global Initiative for Asthma (GINA) strategy recommendations applicable to the Canadian context?”  A conversation between the Canadian Thoracic Society Asthma Assembly and Professor Helen Reddel, Chair of the GINA Scientific Committee. ARTICLE APPEARS IN CANADIAN JOURNAL OF RESPIRATORY, CRITICAL CARE, …

GINA 2019 recommendations about reliever medications in Steps 3-5

We have become aware that the GINA 2019 recommendation for ‘Preferred reliever’ in Steps 3-5 is sometimes being misinterpreted. Please note the following important information. In the GINA 2019 treatment figure for adults and adolescents (Box 3-5A), Steps 3-5 show the medication options for patients with moderate to severe asthma in whom modifiable causes of …

world pneumonia day call to action

Respiratory Groups Call for an End to Preventable Pneumonia Deaths

In support of World Pneumonia Day, 12 November, the Forum of International Respiratory Societies (FIRS), of which Global Initiative for Asthma (GINA) is a member, calls for an end to preventable pneumonia deaths, ensuring equitable access to interventions for prevention and control of pneumonia. Every minute, two children die from pneumonia, representing 16 percent of …

Read the European Respiratory Journal Editorial: GINA 2019: a fundamental change in asthma management

In April 2019, the Global Initiative for Asthma (GINA) (box 1) published new recommendations that might be considered the most fundamental change in asthma management in 30 years. The new recommendations follow a decade-long programme of work by GINA, prompted by concerns about the risks and consequences of the long-standing approach of commencing asthma treatment with …

World Lung Day 2019: Respiratory Groups Unite to Call for Healthy Lungs for All

Cape Town, Glenview, Lausanne, Montevideo, New York, Paris, Tokyo, 25 September 2019 Today, on World Lung Day (WLD), GINA is united with members of the Forum of International Respiratory Societies (FIRS) and WLD partner organisations to advocate for respiratory health globally and call on policymakers to ensure that everyone has access to the services they …

Global study links short-term air pollution exposure to cardiovascular and respiratory mortality, warns international respiratory group

An article published in the New England Journal of Medicine found associations between short-term exposure to particulate matter (PM10 and PM2.5) and cardiovascular and respiratory mortality risk, from over 600 cities across the globe. [1] The adverse health effects of short-term exposure to ambient air pollution have been well documented. Particulate matter (PM) raises public health concerns …